Normal VLDL metabolism despite altered lipoprotein composition in type 1 diabetes mellitus

Clinical Endocrinology

Volumn 55, Issue 6, 2001, Pages 777-787

  Christ, E R ^a,b   Carroll, P V ^a   Albany, E ^a   Umpleby, A M ^a   Lumb, P J ^a   Wierzbicki, A S ^a   Simpson, H L ^a   Sonksen P H ^a   Russell Jones, D L ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b Abteilung für Endokrinologie und Diabetologie für Erwachrene   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B100; GROWTH HORMONE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LEUCINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SOMATOMEDIN C; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; ATHEROGENESIS; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; FEMALE; GAS CHROMATOGRAPHY; HUMAN; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; KINETICS; LIPID BLOOD LEVEL; LIPOPROTEIN METABOLISM; MALE; MASS SPECTROMETRY; METABOLIC CLEARANCE RATE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN SECRETION; RISK FACTOR;

ADULT; APOLIPOPROTEINS B; AREA UNDER CURVE; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 1; FEMALE; GROWTH HORMONE; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; LIPOPROTEINS, VLDL; MALE;

EID: 0035652667     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2001.01407.x     Document Type: Article

References (38)

1. Effect of diabetes and its control on insulin-like growth factors in the young subject with type 1 diabetes
2. Acute insulin withdrawl and the regulation of plasma triglyceride removal in diabetic subjects
3. Metabolism of apoB and apoC lipoproteins in man: Kinetic studies in normal and hyperlipoproteinemic subjects
4. Insulin regulates insulin-like growth factor-I mRNA in rat hepatocytes
5. Growth hormone deficiency in adulthood and the effects of growth hormone replacement: A review
6. Effects of growth hormone (GH) replacement therapy on very low density lipoprotein apolipoprotein B100 kinetics in patients with adult GH deficiency: A stable isotope study
7. Tracer-to-tracee ratio for analysis of stable isotope tracer data: Link with radioactive kinetic formalism
8. Comparison of immunoturbimetric and Lowry methods for measuring concentration of very low density lipoprotein apolipoprotein B-100 in plasma
9. Increased hepatic secretion of very low density lipoprotein apolipoprotein B100 in heterozygous familial hypercholesterolaemia: A stable isotope study
10. Increased hepatic secretion of very low density lipoprotein apolipoprotein B100 in NIDDM
11. Acute hyperinsulinemia decreases the hepatic secretion of very-low-density lipoprotein apolipoprotein B100 in NIDDM
12. A simultaneous study of the metabolism of apolipoprotein B and albumin in nephrotic patients
13. Insulin-like growth factors (IGFs) and IGF-I treatment in the adolescent with insulin-dependent diabetes mellitus
14. Plasma lipid and lipoprotein disorders in IDDM
15. Increased overnight growth hormone concentrations in diabetic compared with normal adolescents
16. Assembly and secretion of hepatic very low density lipoprotein
17. Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction
18. Blood volume
19. Insulin therapy and GH-IGF-I axis disorders in diabetes: Impact of glycaemic control and hepatic insulinisation
20. Differences in lipoprotein subfraction composition and distribution between type 1 diabetic men and control subjects
21. Free and total insulin-like growth factor I (IGF-I), IGF-binding protein-1 (IGFBP-1) and IGFBP-3 and their relationships to the presence of diabetic retinopathy and glomerular hyperfiltration in insulin-dependent diabetes mellitus
22. Apoprotein composition of very low density lipoproteins of human serum
23. Comparisons of metabolism of apolipoprotein B in normal subjects, obese patients, and patients with coronary heart disease
24. Integrated regulation of very low density lipoprotein triglyceride and apolipoprotein B kinetics in non-insulin dependent diabetes mellitus
25. Sample site selection for tracer studies applying a unidirectional circulatory approach
26. 13C]leucine infusion in man: A method for measuring human intracellular leucine tracer enrichment
27. Dissociation of apoprotein B and triglyceride production in very-low-density lipoproteins
28. Apolipoprotein E phenotyping from serum Western blotting
29. Impact of human growth hormone on plasma lipoprotein concentrations
30. Somatostatin, growth hormone, insulin-like growth factor-1, and diabetes: Friends or foes?
31. Lipoprotein heterogenity and apolipoprotein B metabolism
32. Determination of kinetic parameters of apolipoprotein B metabolism using amino acids labeled with stable isotopes
33. Importance of growth hormone for the induction of hepatic low density lipoprotein receptor
34. Substrate delivery as a determinant of hepatic apoB secretion
35. Double antibody technique for the simultaneous assay of insulin and growth hormone
36. Quantitative and qualitative lipoprotein abnormalities in diabetes mellitus
37. Inappropriately elevated plasma insulin-like growth factor II in relation to suppressed insulin-like growth factor I in the diagnosis of non-islet cell tumor hypoglycaemia
38. Effects of low dose oral contraceptives on very low density and low density lipoprotein metabolism